Location: Home
  • search
  • go
  • Relate News
  • 12/19/2024Palleon and Henlius Collaborate to Advance Glycan Editing for Autoimmu...
  • 12/19/2024BMS China Regains Rights to GPC3 Targeted Drug ABZ-706 in Greater Chin...
  • 12/18/2024Merck and Hansoh Enter into Global License Deal for Investigational Or...
  • 12/18/2024BMS and Fangzhou Forge Strategic Alliance to Advance Digital Healthcar...
  • 12/17/2024Eli Lilly's Alzheimer's Drug Donanemab Secures Approval in China
  • 12/16/2024Everest Medicines Announces Acceptance of the NDA for VELSIPITY
  • 12/16/2024Candid Therapeutics and EpimAb Biotherapeutics Enter Into Research Col...
  • 12/16/2024Mabwell Plans Hong Kong Dual Listing Amid Shifting Market Dynamics  
  • 12/16/2024Sinopharm's Mpox Vaccine Gains Clinical Trial Approval in China
  • 12/15/2024HUTCHMED Announces Breakthru Designation in China for ORPATHYS and TA...
  • 12/15/2024National Healthcare Security Work Conference Highlights Progress and S...
  • 12/13/2024RemeGen Unveils Phase III Study Results of Disitamab Vedotin in HER2-P...
  • 12/13/2024Recent Executive Moves
  • 12/12/2024Shanghai Unveils RMB10 Billion Biopharma M&A Fund to Drive Industry Gr...
  • 12/12/2024Bayer Co.Lab Expands in China with Three New Biotech Partners
  • 12/12/2024Chinese Generic Drug Market Expected to Rise at 10.70% CAGR During 202...
  • 12/12/2024JPO Publicizes the Proposed Results of the 10th National VBP
  • 12/11/2024South China Public Hospitals Slash Salaries Amid Mounting Financial Pr...
  • 12/11/2024Santhera Wins First Chinese Approval for Duchenne Muscular Dystrophy ...
  • 12/10/2024The Proposed BIOSECURE Act Faces Setback in Senate
  • 12/10/2024NHSA and NHC Jointly Issue New Policy Document on Centralized Drug Pro...
  • 12/10/2024Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...
  • 12/10/2024Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...
  • 12/10/2024Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...
  • 12/10/2024Sperogenix's Vamorolone Approved in China for DMD
  • 12/10/2024China Biopharma CDMOs Win Reprieve as Biosecure Act Omitted from US De...
  • 12/10/2024Beijing Hanmi Launches $98.65M Expansion Project Near Capital Airport
  • 12/10/2024China Biopharma Tracker – November 2024 (PharmaDJ)
  • 12/10/2024How Wholly Foreign-Owned Hospitals Can Help China's Health Care Sector...
  • 12/10/2024The New Draft Administrative Measures For Management Of Medical Repres...
  • Page:29/372 Total number of articles:11148: [First][<<] [27] [28] [29] [30] [31] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group